ENHANCED PIRMENOL ELIMINATION BY RIFAMPIN

被引:6
作者
STRINGER, KA [1 ]
CETNAROWSKI, AB [1 ]
GOLDFARB, A [1 ]
LEBSACK, ME [1 ]
CHANG, T [1 ]
SEDMAN, AJ [1 ]
机构
[1] WARNER LAMBERT CO,PARKE DAVIS PHARMACEUT RES DIV,ANN ARBOR,MI
关键词
D O I
10.1002/j.1552-4604.1988.tb05721.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1094 / 1097
页数:4
相关论文
共 15 条
[1]   UPDATE ON RIFAMPIN DRUG-INTERACTIONS [J].
BACIEWICZ, AM ;
SELF, TH ;
BEKEMEYER, WB .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (03) :565-568
[2]   DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].
BRASS, C ;
GALGIANI, JN ;
BLASCHKE, TF ;
DEFELICE, R ;
OREILLY, RA ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158
[3]  
CONNEY AH, 1967, PHARMACOL REV, V19, P317
[4]  
Gibaldi M., 1982, PHARMACOKINETICS, P445
[5]   PIRMENOL KINETICS AND EFFECTIVE ORAL DOSE [J].
HAMMILL, SC ;
SHAND, DG ;
HARRELL, FE ;
ZIMMERMAN, JM ;
REITER, MJ ;
VERGHESE, C ;
PRITCHETT, ELC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :686-691
[6]   PIRMENOL, A NEW ANTIARRHYTHMIC AGENT - INITIAL STUDY OF EFFICACY, SAFETY AND PHARMACOKINETICS [J].
HAMMILL, SC ;
SHANDDG ;
ROUTLEDGE, PA ;
HINDMAN, MC ;
BAKER, JT ;
PRITCHETT, ELC .
CIRCULATION, 1982, 65 (02) :369-375
[7]   INITIAL AND LONG-TERM OUTPATIENT EXPERIENCE WITH PIRMENOL FOR CONTROL OF VENTRICULAR ARRHYTHMIAS [J].
HAMPTON, EM ;
ANDERSON, JL ;
LUTZ, JR ;
NAPPI, JM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) :15-22
[8]   PHARMACOKINETICS AND EFFICACY OF PIRMENOL HYDROCHLORIDE IN THE TREATMENT OF VENTRICULAR DYSRHYTHMIA [J].
LEE, TG ;
GOLDBERG, AD ;
CHANG, T ;
SERKLAND, MT ;
YAKATAN, GJ ;
JOHNSON, EL ;
TOOLE, JG ;
GOLDSTEIN, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) :632-637
[9]  
MIGUET JP, 1977, GASTROENTEROLOGY, V72, P924
[10]   INTERACTION OF CHRONIC DAILY WARFARIN THERAPY AND RIFAMPIN [J].
OREILLY, RA .
ANNALS OF INTERNAL MEDICINE, 1975, 83 (04) :506-508